Our mission is early detection of cancer, so that it can be treated. We work to change the trajectory for cancer mortality, and to bring stakeholders together in order to adopt innovative technologies that are safe and effective.

We are a healthcare provider that is pioneering the development of new technologies for early cancer detection. We are a multidisciplinary team of scientists, engineers and physicians who have developed a powerful next-generation sequencing system (NGS), as well as population-scale studies and the latest computer science and data sciences to solve one of medicine's biggest challenges.

GRAIL has its headquarters in Menlo Park, California, as well as offices in Washington, D.C., North Carolina, the United Kingdom, and elsewhere. The company is supported by global investors, pharmaceutical, technology and healthcare companies.

Visit grail.com for more information.

Community Guidelines: https://bit.ly/3xigb24